Literature DB >> 19212335

The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone.

A M Buhl, G W Novotny, P Josefsson, J E Nielsen, L B Pedersen, C Geisler, L Z Rassenti, T J Kipps, J Jurlander, H Leffers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19212335      PMCID： PMC5283720          DOI： 10.1038/leu.2009.16

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection.

Authors:  Emanuela M Ghia; Sonia Jain; George F Widhopf; Laura Z Rassenti; Michael J Keating; William G Wierda; John G Gribben; Jennifer R Brown; Kanti R Rai; John C Byrd; Neil E Kay; Andrew W Greaves; Thomas J Kipps
Journal:  Blood       Date:  2008-03-07       Impact factor: 22.113

2.  CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia.

Authors:  Pär Josefsson; Christian H Geisler; Henrik Leffers; Jørgen H Petersen; Mette K Andersen; Jesper Jurlander; Anne Mette Buhl
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

3.  Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia.

Authors:  Anne Mette Buhl; Jesper Jurlander; Flemming S Jørgensen; Anne Marie Ottesen; Jack B Cowland; Lise Mette Gjerdrum; Brian V Hansen; Henrik Leffers
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

4.  Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

Authors:  Kostas Stamatopoulos; Chrysoula Belessi; Carol Moreno; Myriam Boudjograh; Giuseppe Guida; Tatjana Smilevska; Lynda Belhoul; Stefania Stella; Niki Stavroyianni; Marta Crespo; Anastasia Hadzidimitriou; Laurent Sutton; Francesc Bosch; Nikolaos Laoutaris; Achilles Anagnostopoulos; Emili Montserrat; Athanasios Fassas; Guillaume Dighiero; Federico Caligaris-Cappio; Hélène Merle-Béral; Paolo Ghia; Frédéric Davi
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

5.  The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.

Authors:  Lijuan Chen; Jianyong Li; Wenjuan Zheng; Yaping Zhang; Yujie Wu; Li Li; Sixuan Qian; Wei Xu
Journal:  Leuk Lymphoma       Date:  2007-09

6.  CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.

Authors:  Anne Mette Buhl; Jesper Jurlander; Christian Hartmann Geisler; Lone Bredo Pedersen; Mette Klarskov Andersen; Pär Josefsson; Jørgen Holm Petersen; Henrik Leffers
Journal:  Eur J Haematol       Date:  2006-03-09       Impact factor: 2.997
  6 in total
  5 in total

1.  CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.

Authors:  David Gonzalez; Monica Else; Dorte Wren; Monica Usai; Anne Mette Buhl; Anton Parker; David Oscier; Gareth Morgan; Daniel Catovsky
Journal:  Haematologica       Date:  2012-08-16       Impact factor: 9.941

2.  Darwinian alchemy: Human genes from noncoding DNA.

Authors:  Adam Siepel
Journal:  Genome Res       Date:  2009-10       Impact factor: 9.043

3.  Analysis of CLLU1 expression levels before and after therapy in patients with chronic lymphocytic leukemia.

Authors:  Anne Mette Buhl; Danelle F James; Donna Neuberg; Sonia Jain; Laura Z Rassenti; Thomas J Kipps
Journal:  Eur J Haematol       Date:  2011-03-23       Impact factor: 2.997

4.  Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.

Authors:  Yi Bai; Junyu Long; Zhisong Liu; Jianzhen Lin; Hanchan Huang; Dongxu Wang; Xu Yang; Fei Miao; Yilei Mao; Xinting Sang; Haitao Zhao
Journal:  J Cell Physiol       Date:  2019-03-27       Impact factor: 6.384

Review 5.  Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.

Authors:  Michele Dal-Bo; Francesco Bertoni; Francesco Forconi; Antonella Zucchetto; Riccardo Bomben; Roberto Marasca; Silvia Deaglio; Luca Laurenti; Dimitar G Efremov; Gianluca Gaidano; Giovanni Del Poeta; Valter Gattei
Journal:  J Transl Med       Date:  2009-08-28       Impact factor: 5.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.